Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02042651
Other study ID # H-3-2013-178
Secondary ID HEH-2013-33
Status Withdrawn
Phase N/A
First received January 10, 2014
Last updated March 23, 2015
Start date February 2014
Est. completion date February 2016

Study information

Verified date March 2015
Source Herlev Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

Introduction:

Chronic pelvic pain with unknown pathology is a condition that affects both men and women. the condition is defined as pelvic pain lasting for a minimum of 6 months without any known etiology eg. cancer, infection or inherent anatomical abnormalities. Low intensity extracorporeal shockwave therapy (LIESWT) enables the practitioner to deliver a small amount of energy approximately 5 cm under the skin of the patient without damaging the skin. This have been shown to increase blood flow and accelerate healing which could also be beneficial in chronic pelvic pain patients.The purpose of this study is to investigate the effects of LIESWT on chronic pelvic pain.

Methods:

All patients will be treated at the Birthe Bonde clinic, in Copenhagen, Denmark.

The investigators anticipate to include 100 chronic pelvic pain patients in the study.

included patients will be randomized into two groups: active treatment or sham treatment.

All patients will be required to provide a urine sample and a semen sample prior to final inclusion. Samples will be analyzed for microbial growth. Furthermore, patients will undergo a digital rectal exploration and finally all patients is required to provide an informed consent in order to be included in the study.

A Storz Doulith SD1 T-Top (CE1275) will be used to generate shockwaves. Patients will receive the treatment once a week until their symptoms have seized or for a maximum of 6 times. Each treatment consists of 3000 shockwaves applied to the perineum with a energy density of 0.25-0.40 millijoule(mJ)/mm2 and a frequency of 3 hz.

Participants will fill out a questionnaire one week before the treatment, one week, four weeks, and twelve weeks after the last treatment.

Possible gains from this study:

The investigators hope to provide further evidence for this treatment and consequently be able to offer the treatment as an alternative to the very limited array of treatments existing for this group of patients today.

Ethics, funding, and publication:

The study is performed in compliance with the Helsinki declaration. External funding have been applied for but not yet received. Participants will be informed of sources of external funding. The result of the study will be published as soon as possible, preferably in a peer-reviewed international journal.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- pelvic pain with a duration of more than 6 months

- be able to read and understand the study information

Exclusion Criteria:

- known etiology for pelvic pain eg. cancer, infection, inherent abnormalities.

- diagnosed with hemophilia

- receiving anti thrombotic therapy other than hearth magnyl

- diagnosed with thrombocytosis

- active cancer

- treated with IV glucocorticoids within the last 6 months

- disease in the rectal area

- abnormal digital rectal exploration

- bacteriospermia

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Low intensity extracorporeal shockwave therapy
Shockwaves will be applied to the perineum a total of 6 times once per week. The energy level applied will range between 0.25 and 0.40 mJ/mm2 with a frequency of 3 Hz for a total of 3000 shockwaves per treatment session
Sham low intensity extracorporeal shockwave therapy
Shockwaves will be applied to the perineum a total of 6 times once per week. The shockwaves will be blocked by a medium on the handheld applicator.

Locations

Country Name City State
Denmark Birthe bonde klinikken Copenhagen E Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Herlev Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in NIH-Chronic Prostatitis Symptom Index A questionnaire designed to provide symptom scores for patients with chronic prostatitis. The index provides scores on pain, urinary symptoms, and quality of life. Change from baseline to twelve weeks after final treatment No
Secondary Change in The International Index of Erectile Function 5 Questionnaire designed to evaluate erectile capabilities. The questionnaire provides a score between 5 and 25. Change from baseline to twelve weeks after final treatment No
Secondary Change in The International prostate symptom score A questionnaire designed to provide information on lower urinary tract symptoms and their impact on quality of life. scores range from 0 to 35. Change from baseline to twelve weeks after final treatment No
Secondary Global satisfaction score One question designed to estimate treatment satisfaction on a four point Likert scale. Twelve weeks after final treatment No
See also
  Status Clinical Trial Phase
Completed NCT03638856 - Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT01020162 - Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain N/A
Recruiting NCT05836454 - The Soft Tissue Mobilization Techniques on PMS N/A
Completed NCT02372903 - Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis N/A
Recruiting NCT05185180 - Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Recruiting NCT05970783 - A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease Phase 3
Completed NCT04615247 - Program to Overcome Pelvic Pain Study N/A
Completed NCT02721108 - Mindfulness Meditation for Chronic Pelvic Pain Management N/A
Not yet recruiting NCT00844012 - Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain Phase 4
Recruiting NCT04976751 - Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China Phase 1
Withdrawn NCT04252040 - Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP) N/A
Completed NCT01802528 - Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients N/A
Completed NCT03175809 - Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain N/A
Recruiting NCT05324280 - Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain N/A
Not yet recruiting NCT02556411 - Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) N/A
Completed NCT04104542 - MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women N/A
Completed NCT01553201 - Botulinum Toxin for Pelvic Pain in Women With Endometriosis Phase 1/Phase 2
Completed NCT03617627 - Self-management Program in Chronic Pelvic Pain N/A
Recruiting NCT06019091 - Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults N/A